Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Brain Research. Molecular Brain Research|June 1, 1997
The melanin-concentrating hormone gene in human: flanking region analysis, fine chromosome mapping, and tissue-specific expressionA Viale, Y Zhixing, C Breton, et al.Molecular Biology and Evolution|November 9, 2000
Structure and expression of the variant melanin-concentrating hormone genes: only PMCHL1 is transcribed in the developing human brain and encodes a putative proteinA Viale, A Courseaux, F Presse, et al.Revista Argentina De Microbiologia|January 1, 1980
[Bacteriochlorophyll a synthesis in Rhodopseudomonas palustris]A A Viale, A S Lorenti, E A Wider de Xifra, et al.Molecular Biology and Evolution|March 10, 1998
Emergence of a brain-expressed variant melanin-concentrating hormone gene during higher primate evolution: a gene "in search of a function"A Viale, C Ortola, F Richard, et al.Bone Marrow Transplantation|April 21, 2001
Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reactionF Leone, E Perissinotto, A Viale, et al.The Journal of Biological Chemistry|February 26, 1999
Cellular localization and role of prohormone convertases in the processing of pro-melanin concentrating hormone in mammalsA Viale, C Ortola, G Hervieu, et al.Cancer|December 24, 1997
Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implantsG Mariani, A Lasku, E Balza, et al.Journal of Oncology|March 26, 2011
Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological AbnormalitiesM Affer, S Dao, C Liu, et al.Cancer|December 24, 1997
A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumorsG Mariani, A Lasku, A Pau, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2010
Phase II trial of neoadjuvant temozolomide in resectable melanoma patientsG D Shah, N D Socci, J S Gold, et al.Pageof 5